Exercise and Neutrophil Function in COPD
A Pilot Study to Examine the Effect of Acute Exercise on Neutrophil Function in Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
Exercise is a cornerstone of pulmonary rehabilitation in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Although researchers have shown numerous benefits with exercise in COPD patients, most studies have only looked at exercise tolerance and psychological outcomes following training. COPD is characterised by persistent inflammation that can cause progressive decline in lung function and multisystemic complications. This inflammation can be amplified in patients when they suffer acute exacerbations. There is a wellknown relationship between exercise, immune function and risk of infection. Exercise has also been shown to have an antiinflammatory effect when performed regularly. There is a lack of research looking into the inflammatory or immune response to exercise in patients with COPD. The exercise within this study will be individually tailored to patients with COPD based on their validated 6 minute walk test (6MWT) but the protocol will involve interval exercise that has been used previously. This type of exercise is considered most appropriate for research into mechanisms of benefit because it maintains the exercise training effects of other modalities (e.g. continuous low intensity aerobic exercise) while avoiding the occurrence of limitations to exercise in people with lung problems (e.g. dynamic hyperinflation). It also closely mirrors daily activity of someone with COPD. The investigators want to explore the effects of exercise specifically on immune function in 15 people COPD and compare any changes to 15 Controls. By better understanding the mechanisms of how exercise affects inflammation, the investigators could eventually design better Pulmonary Rehabilitation interventions, especially for those most at risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 7, 2014
CompletedFirst Posted
Study publicly available on registry
April 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedOctober 13, 2014
October 1, 2014
4 months
April 7, 2014
October 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neutrophil response to exercise
The primary outcome measure for this study is to examine neutrophil responses to acute exercise, including changes in the counts and function of these cells in blood and sputa in order to compare any changes between COPD and age-gender matched controls.
4 months
Secondary Outcomes (1)
Different health status and the responses on neutrophil function
4 months
Other Outcomes (2)
Effect of inhaled steroids on neutrophil response following exercise
4 months
Neutrophil response to exercise in past smokers versus non-smokers
4 months
Study Arms (1)
Interval Exercise
EXPERIMENTALSubjects will undertake an interval exercise session (on a harnessed treadmill) (HP Cosmos Mercury 4.0, HP Cosmos Sports and Medical Gmbh, Nussdorf-Traustein,Germany) based on the average speed calculated from the 6 minute walk test (6MWT). Intervals are based on the work previously done by Mador et al., 2009 who used intervals of 150% (for 1 minute) followed by intervals of 75% (for 2 minutes) based on 80% average speed from the 6 minute walk test. This study repeated these intervals 7 times with a duration of 23 minutes in total for the exercise intervention with the 75% intervals at the start and at the end of the exercise session. No warm up was undertaken for this method as it was a walking exercise test and the risk of injury was minimised with use of the harnessed treadmill.
Interventions
Eligibility Criteria
You may qualify if:
- COPD group - 15 Participants who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. \>10 pack-year smoking history and post-bronchodilator spirometry FEV1/FVC ratio \<0.70 and FEV\<80%) and have completed at least 12 from 18 sessions of a pulmonary rehabilitation programme.
- Age 50-80 years.
- Current non-smoker.
- Control group - 15 Participants who will act as Controls, without COPD or cardiovascular disease
- Age 50-80 years (ideally of similar gender distribution)
- Current non-smoker.
- Spirometry: FEV1/FVC\>0.7 and FEV\>80% predicted
You may not qualify if:
- Known asthma or allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
- A change in any medications within 4 weeks or during the study.
- Require domiciliary oxygen.
- Acute exacerbation of COPD within 4 weeks of study entry.
- Any infection or illness within 4 weeks of study entry.
- Other active inflammatory conditions e.g. rheumatoid arthritis, cancer, unstable cardiac conditions.
- Receiving oral steroids or other immunomodulating drugs.
- Currently undergoing exercise training (including Pulmonary Rehabilitation).
- Any previous cardiovascular contraindications to exercise (e.g. unstable angina).
- Inability to complete the 6MWT due to physical or mental impairment.
- Exhaled CO\>10ppm or smoked any cigarettes within 6 months.
- Inability or unwillingness to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince Philip Hospital
Llanelli, Carmarthenshire, SA14 8QF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alex R Jenkins, BSc (Hons)
Aberystwyth University
- STUDY CHAIR
Keir E Lewis, MD
Hywel Dda Health Board
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Student
Study Record Dates
First Submitted
April 7, 2014
First Posted
April 28, 2014
Study Start
March 1, 2014
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
October 13, 2014
Record last verified: 2014-10